HyperlynX: A Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and Radiotherapy in Patients with Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck

被引：0
|
作者：
Saba, N. F. [1 ]
Sukari, A. [2 ]
Forget, F. [3 ]
Popovtzer, A. [4 ]
Perez, J. Rubio [5 ]
Park, J. H. [6 ]
Yang, M. H. [7 ]
Sato, M. [8 ,9 ]
Kuipers, M. [10 ]
Ito, R. [8 ,9 ]
Salmioll, S.
机构：
[1] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[2] Karmanos Canc Inst, Detroit, MI USA
[3] Ctr Hosp Ardenne, Libramont, Belgium
[4] Hadassah Med Ctr Ein Kerem, Jerusalem, Israel
[5] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain
[6] Konkuk Univ, Med Ctr, Seoul, South Korea
[7] Taipei Vet Gen Hosp, Div Med Oncol, Dept Oncol, Ctr Immunooncol, Taipei, Taiwan
[8] Merck Biopharma Co Ltd, Merck KGaA, Darmstadt, Germany
[9] Merck Biopharma Co Ltd, Merck KGaA, Tokyo, Japan
[10] Merck KGaA, Healthcare Business, Darmstadt, Germany
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
115
引用
收藏
页码：E21 / E21
页数：1
相关论文
共 50 条
  • [31] A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma
    Grégoire, V
    Ang, KK
    Rosier, JF
    Beauduin, M
    Garden, AS
    Hamoir, M
    Hittelman, WN
    Humblet, Y
    Khuri, FR
    Milas, L
    Mitine, C
    Scalliet, P
    RADIOTHERAPY AND ONCOLOGY, 2002, 63 (02) : 187 - 193
  • [32] Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma (vol 14, 226, 2023)
    Uchinami, Yusuke
    Yasuda, Koichi
    Kano, Satoshi
    Otsuka, Manami
    Hamada, Seijiro
    Suzuki, Takayoshi
    Tsushima, Nayuta
    Takahashi, Shuhei
    Fujita, Yoshihiro
    Miyazaki, Tomohiko
    Higaki, Hajime
    Taguchi, Jun
    Shimizu, Yasushi
    Sakashita, Tomohiro
    Homma, Akihiro
    Aoyama, Hidefumi
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [33] Phase I/II study of erlotinib (TARCEVA®) combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Fonseca, Allex J.
    Herchenhorn, Daniel
    Dias, Fernando L.
    Pineda, Rodrigo M.
    Ferreira, Carlos G.
    Bezerra, Marcos
    Knust, Renata
    Fontao, Karina
    Martins, Renato G.
    ANNALS OF ONCOLOGY, 2006, 17 : 180 - 180
  • [34] WEEKLY GEMCITABINE AND CISPLATIN IN COMBINATION WITH RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED HEAD-AND-NECK CANCER: PHASE I STUDY
    Viani, Gustavo Arruda
    Afonso, Sergio Luis
    Tavares, Vivian Cardoso
    Bernardes da Silva, Lucas Godoi
    Stefano, Eduardo Jose
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : E231 - E235
  • [35] A phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinoma
    Ang, Mei-Kim
    Montoya, Jose Enrique
    Tharavichitkul, Ekkasit
    Lim, Cindy
    Tan, Terence
    Wang, Lan Ying
    Wee, Joseph
    Soong, Yoke-Lim
    Fong, Kam-Weng
    Ng, Quan Sing
    Tan, Daniel Shao-Weng
    Toh, Chee-Keong
    Tan, Eng-Huat
    Lim, Wan-Teck
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (05): : 1641 - 1651
  • [36] XRay Vision: A Phase 3 Study of Xevinapant Plus Radiotherapy (RT) for High-risk, Cisplatin-ineligible Patients with Resected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA SCCHN)
    Ferris, R. L.
    Mehanna, H.
    Schoenfeld, J. D.
    Tahara, M.
    Yom, S. S.
    Haddad, R. I.
    Koenig, A.
    Salmio, S.
    Bajars, M.
    Le Tourneau, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E17 - E18
  • [37] Gemcitabine versus cisplatin concomitant with radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Ali, Elsayed Mostafa
    Hassan, Emad Nabil
    Elyamany, Ashraf
    Maklad, Ahmed M.
    Abdelraheem, Ahmed Gaber
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [38] Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma A meta-analysis
    Tang, Wen-Hua
    Sun, Wei
    Long, Guo-Xian
    MEDICINE, 2020, 99 (36)
  • [39] Toxicity and efficacy of accelerated radiotherapy with concurrent weekly cisplatin for locally advanced head and neck carcinoma
    Driessen, Chantal M. L.
    Janssens, Geert O.
    van der Graaf, Winette T. A.
    Takes, Robert P.
    Merkx, Thijs A. W.
    Melchers, Willem J. G.
    Kaanders, Hans A. M.
    van Herpen, Carla M. L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E559 - E565
  • [40] Xevinapant with radiation and concurrent carboplatin and paclitaxel in patients ineligible for cisplatin with locoregionally advanced squamous cell carcinoma of the head and neck (EXtRaCT study)
    Mir, Nabiel Ali
    Juloori, Aditya
    Swiecicki, Paul
    Katipally, Rohan Reddy
    Agrawal, Nishant
    Blair, Elizabeth A.
    Haraf, Daniel J.
    Pearson, Alexander T.
    Vokes, Everett E.
    Rosenberg, Ari Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345